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Priming of insulin secretory granules for release
requires intragranular acidification and depends on
vesicular Cl-fluxes, but the identity of the chloride
transporter/ion channel involved is unknown. We
tested the hypothesis that the chloride transport
protein ClC-3 fulfills these actions in pancreatic
b cells. In ClC-3/ mice, insulin secretion evoked
by membrane depolarization (high extracellular K+,
sulfonylureas), or glucose was >60% reduced com-
pared to WT animals. This effect was mirrored by
a 80% reduction in depolarization-evoked b cell
exocytosis (monitored as increases in cell capaci-
tance) in single ClC-3/ b cells, as well as a 44%
reduction in proton transport across the granule
membrane. ClC-3 expression in the insulin granule
was demonstrated by immunoblotting, immunos-
taining, and negative immuno-EM in a high-purifica-
tion fraction of large dense-core vesicles (LDCVs)
obtained by phogrin-EGFP labeling. The data estab-
lish the importance of granular Cl fluxes in granule
priming and provide direct evidence for the involve-
ment of ClC-3 in the process.
INTRODUCTION
A low intragranular pH is crucial for prohormone cleavage in
pancreatic b cells (Hutton, 1989). In addition, the acidification
of secretory vesicles may play a role in making them release-
competent, an ATP-dependent process referred to as priming
(Barg et al., 2001; Rorsman and Renstro¨m, 2003). Acidification
is carried out by a V-type H+-ATPase that pumps H+ into the
vesicular lumen. Without charge compensation, this electro-
genic process leads to a lumen-positive voltage across the gran-
ular membrane that would prevent further proton pumping.
Acidic organelles of the endosomal pathway principally depend
on Cl fluxes for charge neutralization (al-Awqati, 1995; Sona-Cewane and Verkman, 2003). Consistent with such a mechanism,
procedures inhibiting transmembrane Cl fluxes in b cell gran-
ules impair their luminal acidification and their priming for exocy-
tosis (Barg et al., 2001).
Various members of the ClC family of Cl transport proteins
facilitate the acidification of intracellular vesicles (Hara-Chikuma
et al., 2005; Piwon et al., 2000; Stobrawa et al., 2001). ClC-3 is
present on endosomes and synaptic vesicles (SVs) (Salazar
et al., 2004; Stobrawa et al., 2001), and acidification rates in
both types of vesicle were reduced in ClC-3 knockout (KO)
(ClC-3/) mice (Stobrawa et al., 2001; Yoshikawa et al., 2002).
In addition, ClC-3 has also been proposed to be present in
b cell secretory granules (Barg et al., 2001). Functional experi-
ments indicate that ClC-3 facilitates insulin secretion by
enhancing the acidification of insulin-containing granules (Barg
et al., 2001; Juhl et al., 2003). Here, we have addressed this
possibility using constitutive ClC-3 KO mice.
RESULTS
ClC-3 Dependence of Insulin Processing and Secretion
Insulin secretion was measured in static batch incubations
(Figure 1A). In WT islets, the sulfonylurea glibenclamide (2 mM)
and high extracellular K+ (50 mM) stimulated insulin secretion
3.1- and 3.4-fold over basal. Glucose (20 mM) was a much
stronger secretagogue and resulted in an 10-fold stimulation,
the latter effect being enhanced 1.8-fold by glucagon-like
peptide 1 (GLP-1) (100 nM). In ClC-3-deficient (ClC-3/) islets,
the stimulatory effects of glibenclamide and high K+ were abol-
ished, whereas the stimulatory effect of glucose was reduced
by 67%. GLP-1 remained stimulatory (179% ± 21%; p < 0.01)
in ClC-3/ islets, but secretion was nevertheless reduced by
57% relative to WT values. We then investigated the possible
effect of ClC-3 on proinsulin processing in a subset of the exper-
iments (Figure 1C). In both WT and ClC-3/ islets, proinsulin
secretion was barely detectable under basal conditions (1 mM
glucose). Also, in high glucose (20 mM), release of mature insulin
strongly dominated (>98%) over that of proinsulin. Although the
molar ratio of insulin/proinsulin release was significantly lower in
ClC-3/ islets compared to WT (Figure 1D), these data showll Metabolism 10, 309–315, October 7, 2009 ª2009 Elsevier Inc. 309
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Ablation of ClC-3 Suppresses Insulin SecretionFigure 1. Effects of ClC-3 Ablation on In Vitro Hormone Release and Intracellular Calcium Homeostasis
(A) Insulin secretion measured from WT (black) and ClC-3/ islets (gray) in vitro during 1 hr static incubations in the presence of 1 mM glucose, 1 mM glucose +
1 mM glibenclamide (G), 1 mM glucose at 50 mM extracellular K+, 20 mM glucose, and 20 mM glucose + 100 nM GLP-1 as indicated.
(B) Islet insulin content from WT (black) and KO (gray) islets.
(C) As in (A), but insulin and proinsulin were measured at 1 and 20 mM glucose.
(D) Ratio of insulin over proinsulin secretion in 20 mM glucose. Data are mean values ± SEM of 9–23, 6–8, and 5–6 experiments (data were pooled for each animal)
under the different conditions in (A), (B), and (C) and (D), respectively. **p < 0.01 and ***p < 0.001.
(E) Intracellular [Ca2+]i recordings in WT and ClC-3
/ islets. Glucose was increased from 5 to 15 mM and tolbutamide included in the medium as indicated. Data
are representative for seven (WT) and ten (ClC-3/) experiments.that the strong secretion defect of the ClC-3/ islets cannot be
attributed to impaired insulin processing. In agreement with this
conclusion, insulin content was reduced by only 10% in ClC-
3/ islets (Figure 1B). Although pancreatic a cells also express
ClC-3 (Maritzen et al., 2008), glucagon secretion was unaffected
by ablation of ClC-3 (Figure S1).
Ca2+ Homeostasis Is Unaffected by ClC-3 Ablation
Glucose stimulates insulin secretion by induction of Ca2+-
dependent electrical activity that triggers exocytosis of the
insulin granules. We monitored [Ca2+]i in WT and ClC-3
/
islets (Figure 1E). Basal [Ca2+]i levels were 88 ± 6 nM and310 Cell Metabolism 10, 309–315, October 7, 2009 ª2009 Elsevier106 ± 15 nM in WT (n = 7) and ClC-3/ (n = 10) islets, respec-
tively. Following stimulation with 15 mM glucose, [Ca2+]i rose to
a peak value of 419 ± 52 nM and 452 ± 29 nM in WT and ClC-
3/ islets. In both cases, this peak was followed by [Ca2+]i
oscillations due to bursts of Ca2+-dependent action potentials.
The addition of the sulfonylurea tolbutamide (0.1 mM) increased
[Ca2+]i similarly in WT and KO islets, and peak [Ca
2+]i averaged
414 ± 47 nM and 458 ± 39 nM, respectively. Thus, if anything,
[Ca2+]i is higher in ClC-3-deficient than in WT islets. The
suppression of insulin secretion must therefore involve
processes downstream of metabolic sensing, electrical activity,
and [Ca2+]i signaling.Inc.
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Ablation of ClC-3 Suppresses Insulin SecretionFigure 2. Effects of ClC-3 Ablation on Regulated b Cell Exocytosis and Secretion
(A) Increases in membrane capacitance (DC), evoked by a train of ten 500 ms voltage-clamp depolarizations from70 mV to 0 mV (V) in a WT b cell (identified by
Na+ current inactivation properties; inset).
(B) Increases in membrane capacitance elicited by the individual pulses of the train stimulus (DCn  DCn  1).
(C and D) Same as in (A) and (B), but using cells from ClC-3/ mice.
(E and F) Same as in (C) and (D), but ClC-3 had been reintroduced by Semliki Forest Virus (SFV). Data represent mean values ± SEM obtained from 14, 14, and
5 cells in (B), (D), and (F), respectively. ***p < 0.001 and **p < 0.01.
(G) Silencing of ClC-3 demonstrated by western blot analysis of INS-1 cells treated with vector-based RNAi against ClC-3 with either a scrambled control oligo (C)
or silencing oligos S1–S3.
(H) Stimulated hGH secretion from control INS-1 cells and cells in which ClC-3 had been downregulated using S3. Data are mean values ± SEM of six experi-
ments.
(I) Increases in membrane capacitance in ClC-3-silenced cells (gray bars) elicited by the individual pulses of the train stimulus (DCn  DCn  1). The black line
shows data from control cells.
(J) Total increase in DC (DCTOT) in ClC-3-silenced cells (gray bar) and cells treated with a scrambled oligo (black bar). Data in (I) and (J) are mean values ± SEM of
11 and 6 experiments, respectively. **p < 0.01 and *p < 0.01.Defective Exocytosis in ClC-3 Null b Cells
We next compared the exocytotic capacity of isolated WT and
ClC-3/ b cells. The b cell identity was established by the pres-
ence of a voltage-gated Na+ current that inactivated with a V0.5 of
100 mV (Olofsson et al., 2002). Exocytosis was elicited by
trains of ten 500 ms depolarizations from 70 mV to 0 mV. InCeWT b cells, exocytosis proceeded throughout the train stimulus
(Figure 2A). The capacitance increase per pulse decreased
from an average of75 fF in response to the initial depolarization
to a final value of 10 fF/pulse (Figure 2B). The total capacitance
increase of control cells averaged 381 ± 36 fF (n = 14). In ClC-3
KO b cells, the capacitance increases per pulse were muchll Metabolism 10, 309–315, October 7, 2009 ª2009 Elsevier Inc. 311
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Ablation of ClC-3 Suppresses Insulin SecretionFigure 3. Expression of ClC-3 in Isolated Insulin Granules and Reduced Granular Proton Permeability in ClC-3/ b Cells
(A) Exocytosis measured in WT and ClC-3/ b cells during intracellular dialysis with 1.5 mM [Ca2+]i.
(B) Changes in granular pH following establishment of whole-cell configuration and wash-in of 0.1 mM CCCP in WT and ClC-3/ b cells. The whole-cell config-
uration was established at t = 0. Data are given as mean fluorescence values ± SEM normalized to fluorescence intensity at t = 0 of five control cells and nine ClC-
3/ cells. *p < 0.05.
(C) Presence of ClC-3 in INS-1 postnuclear cell homogenates (HM), as well as enrichment in insulin-containing secretory granules (SG) purified by fluorescence-
activated ‘‘cell’’ sorting after tagging the vesicles with phogrin-EGFP. The same fractions were also tested for immunoreactivity against markers of plasma
membrane (NaK ATPase), lysosomes (Cathepsin B), SLMVs (synaptophysin), early (Rab4) and recycling (Rab11) endosomes, and mitochondria (Cytochrome C).
(D) Confocal imaging of insulin and ClC-3 immunoreactivity in EGFP-tagged insulin granules. Scale bar, 400 nm.
(E) Negative immuno-EM of an EGFP-tagged LDCV, demonstrating coexpression of ClC-3 (25 nm gold particle) and insulin (5 nm particle), representative of >300
single granules studied.smaller throughout the train (Figures 2C and 2D), reaching
a maximum rate of 20 fF/pulse, with the total capacitance
increase being a mere 70 ± 12 fF (p < 0.001 versus control; n =
14). The secretory response of b cells lacking ClC-3 was largely
normalized by infecting the cells with a recombinant Semliki
Forest Virus (SFV) encoding ClC-3 (Figures 2E–2F), the total
capacitance increase averaging 259 ± 18 fF (n = 5; p < 0.001
versus ClC-3/).
These findings corroborate the insulin release data (Figure 1)
and further suggest that the secretion defect is a cell-intrinsic
consequence of the lack of ClC-3 and not due to systemic/para-
crine effects. The latter conclusion is supported by RNAi-medi-
ated silencing of ClC-3 in INS-1 cells. Western blotting with
densitometric analysis revealed that ClC-3 was reduced by
70% within 72 hr (Figure 2G). This correlated with a 22% ±
5% (p < 0.01 silencer versus control) (Figure 2H) inhibition of
stimulated GH release (GH used as an insulin proxy to detect
secretion in transfected cells) (Ivarsson et al., 2005) and a marked
65% decrease (p < 0.05 versus control) in exocytosis elicited by
trains of depolarization (Figures 2I and 2J).312 Cell Metabolism 10, 309–315, October 7, 2009 ª2009 Elsevier IClC-3 Control of Insulin Granule Acidification
and Priming
How does ablation of ClC-3 suppress exocytosis? We tested
whether ClC-3 is important for granule priming. Exocytosis was
elicited by an intracellular [Ca2+]i dialysis protocol (1.5 mM free
[Ca2+]i with 3 mM Mg-ATP and 0.1 mM cAMP) (Figure 3A). In
WT b cells, cell capacitance increased by 1.2 ± 0.15 pF over
60 s, equivalent to the fusion of 400 secretory granules (Mac-
Donald et al., 2006). For comparison, exocytosis of the readily
releasable pool (RRP) of primed insulin granules corresponds
to a capacitance increase of only 0.1 pF or 33 granules. The
steady-state rate of capacitance increase provides an estimate
of the rate of mobilization of new granules to the RRP and aver-
aged 20 ± 2 fF/s (n = 15). In ClC-3/ b cells, the rate of capac-
itance increase was limited to 12 ± 1 fF/s (n = 19; p < 0.01 versus
WT). Thus, mobilization was reduced by 40% in b cells lacking
ClC-3.
ClC-3 has been proposed to promote mobilization by
providing a shunt conductance that allows the granule interior
to acidify (Barg et al., 2001; Maritzen et al., 2008). In Figure 3B,nc.
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Ablation of ClC-3 Suppresses Insulin Secretionwe tested whether ablation of ClC-3 affects intragranular pH
using the fluorescent probe LysoSensor Green DND-189
(LSG). The protonophore CCCP (0.1 mM) was introduced to
the cytosol using a patch pipette. Addition of CCCP at t = 0 led
to a prompt reduction of fluorescence as the intragranular pH
increased and fluorescent probe moved out of the cell. CCCP-
mediated H+ efflux from the granule is electrogenic. In the
absence of a counterion, a large electrical potential will rapidly
develop when the H+ permeability is increased that would
prevent pH equilibration across the granule membrane. If ClC-3
Cl channel activity is required for proton translocation over the
granule membrane, then loss of these channels should reduce
H+ efflux via the protonophore, leading to a reduced loss of fluo-
rescence. Indeed, the CCCP-induced fluorescence decrease at
steady state (90 s after addition of CCCP) was reduced from
41% ± 9% in WT cells to 18% ± 5% in ClC-3/ b cells (*p <
0.05). Thus, it appears that ClC-3 represents a quantitatively
important shunt conductance in b cell granules. The validity of
LSG as a reporter of changes in intragranular pH was also veri-
fied (Figure S2).
Figure 4. Effects of ClC-3 Ablation on b Cell Ultra-
structure and In Vivo Insulin Secretion
(A and B) Typical electron micrographs of WT and ClC-3/
b cells.
(C and D) Total number (C) and number of granules docked
with the plasma membrane (D) in WT and ClC-3/ mice as
indicated. Data in (A)–(D) represent mean values ± SEM calcu-
lated from three and four animals per genotype. Scale bars,
0.5 mm.
(E) Changes in plasma glucose (upper) and plasma insulin
concentration (lower) following an intraperitoneal glucose
challenge. Two grams glucose per kilograms body weight
was administered at t = 0. Serum insulin and glucose concen-
trations were measured before and 3 and 8 min after injection.
(F) Same as in (E), but insulin secretion was stimulated with gli-
benclamide (500 mg/kg body weight). Data in (E) and (F) are
mean values ± SEM from 12 WT and 13 ClC-3/ mice in (E)
and 7 WT and 8 ClC-3/ mice in (F). **p < 0.01.
Subcellular Localization of ClC-3
Which acidic cellular compartments exhibit ClC-3-
dependent pH regulation? Earlier immunocyto-
chemical data indicate that ClC-3 is present in
membranes of insulin-containing secretory gran-
ules (Barg et al., 2001), but subsequent islet frac-
tionation data suggest that the transporter is rather
enriched in lighter (endosome/synaptic-like micro-
vesicle [SLMV]) fractions (Maritzen et al., 2008).
To obtain a highly enriched fraction of insulin gran-
ules, a fusion protein containing EGFP and phogrin,
a highly selective marker of the LDCVs (Hutton,
1989), was expressed in insulin-secreting INS-1
cells, followed by immunoprecipitation using an
antibody directed against EGFP (Varadi et al.,
2005). Granules isolated by EGFP labeling were
enriched for insulin by a factor of 20 over the
homogenate when normalized to protein content.
Similarly, this fraction contained significant ClC-3
immunoreactivity at levels that were >20-fold en-
riched above those in the homogenate, but did not exhibit immu-
noreactivity for markers of other membrane compartments
(Figure 3C). Confocal immunocytochemistry in single sorted
granules demonstrated insulin immunoreactivity in >95% of the
single granules that exhibited both EGFP and ClC-3 expression
(n = 26) (Figure 3D). This finding was further substantiated by
negative immuno-EM of the sorted insulin granules, which
demonstrated coexpression of ClC-3 in >80% of the granules
(n > 300) without noticeable unspecific background staining
(Figure 3E). Similar data were also obtained by conventional
immuno-EM (Figure S3).
Normal b Cell Ultrastructure in ClC-3 Null Mice
ClC-3 ablation did not interfere with granule biogenesis. Ultra-
structural analyses revealed that the number of granules (total
as well as docked) remained unchanged in ClC-3/ islets.
Moreover, their appearance and diameter were unaltered (Fig-
ures 4A–4D). The diameters averaged 333 ± 8 nm (n = 1638 gran-
ules; n = 4 animals) and 329 ± 8 nm (n = 1279 granules; n = 3
animals) in WT and ClC-3/ b cells, respectively. These findingsCell Metabolism 10, 309–315, October 7, 2009 ª2009 Elsevier Inc. 313
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absence of ClC-3 and agree with the marginal decrease in islet
insulin content (Figure 1B).
ClC-3 Controls In Vivo Insulin Secretion
To determine the systemic consequences of the ClC-3 defi-
ciency on glucose homeostasis and insulin release, serum insulin
and glucose concentrations were finally measured in WT and
ClC-3/ mice after an intraperitoneal glucose challenge (2 g/kg
body weight). Control mice responded to the glucose chal-
lenge with an increase in plasma insulin levels both at 3 and 8
min, but no such response was detected in ClC-3 KO mice
(Figure 4E). Likewise, glibenclamide (500 mg/kg body weight),
which in WT mice evoked a transient stimulation of insulin secre-
tion, failed to enhance insulin secretion in ClC-3-deficient mice
(Figure 4F).
DISCUSSION
Secretory granules must undergo a priming reaction to gain
release competence. We have previously proposed that priming
of insulin granules requires the acidification of their lumen (Barg
et al., 2001), and data in favor of this hypothesis have been
reported (Stiernet et al., 2006). Previous evidence suggestive
of a role of ClC-3 in insulin secretion involved immunoinhibition
(Barg et al., 2001) and antisense approaches (Juhl et al., 2003)
to suppress ClC-3. However, these procedures can always be
questioned for the risk of unspecific effects. Here, we have revis-
ited the role of ClC-3 in insulin secretion by analyzing mice in
which these channels had been genetically removed. The new
data presented here provide additional evidence that ClC-3
plays a role in insulin secretion.
The reduced insulin secretion capacity of ClC-3/ b cells is
evident from the islet batch incubations (Figure 1) as well as
the reduced rates of replenishment of the RRP of granules in
the Ca2+ infusion experiments (Figure 3). Furthermore, in accor-
dance with the notion that ClC-3 provides a shunt conductance
required for granule acidification and priming, H+ fluxes and
priming were reduced by 50% in ClC-3/ b cells (Figure 3).
However, the finding that these processes were not abolished
argues that there exist additional mechanisms for granule
priming/acidification in the b cell. It is likely that these processes
account for the normality of basal plasma insulin and glucose
levels in the KO animals. It is only when insulin secretion must
increase much beyond basal that the demand of secretory gran-
ules exceeds that which can be met by the ClC-3-independent
mechanisms.
It may seem surprising that the ClC-3/ mouse is not overtly
diabetic. However, it should be noted that they retain a certain
degree of glucose-stimulated insulin secretion, which is a likely
explanation for the relatively mild phenotype. In addition, only
30% of glucose tolerance in mice is mediated by insulin, and
noninsulin-dependent mechanisms are significant (Pacini et al.,
2001). We cannot entirely exclude the possibility that systemic
effects due to the global KO of ClC-3 contribute to the effect.
However, this possibility seems less likely given the in vitro find-
ings, e.g., that the effects of ClC-3 ablation on single-cell exocy-
tosis can be reversed by infection of ClC-3. This conclusion is
underpinned by the finding that siRNA-mediated downregulation314 Cell Metabolism 10, 309–315, October 7, 2009 ª2009 Elsevier Iof ClC-3 in INS-1 cells is associated with a significant reduction
of secretion.
We acknowledge that large dense-core vesicles (LDCVs) may
not be the sole location of ClC-3. Indeed, the protein appears to
enrich in neuronal SVs (Stobrawa et al., 2001), in endosomes and
SLMVs of neuroendocrine PC12 cells (Salazar et al., 2004), as
well as in b cells (Maritzen et al., 2008). However, the data pre-
sented here indicate that insulin granule membrane contains
significant levels of ClC-3 (Figures 3C–3E). These data provide
strong argument for a direct role of ClC-3 in b cell exocytosis
and in vivo insulin secretion. It is of interest that exocytosis in
adrenal chromaffin cells was also reduced in the same ClC-3/
KO mouse model (Maritzen et al., 2008), although the mecha-
nisms involved were not examined in detail. Collectively, these
findings raise the interesting possibility that ClC-3 may play
a more general role in the priming and exocytosis of LDCVs in
endocrine cells.
EXPERIMENTAL PROCEDURES
Animals and In Vivo Experiments
ClC-3/ and ClC-3+/+ littermates were used in these experiments. Details of
the generation of the mice and their other characteristics have been summa-
rized elsewhere (Stobrawa et al., 2001). The mice were generated in Hamburg
and transported to Lund at least 2 weeks prior to the functional experiments.
Blood sampling in the in vivo experiments were conducted as described
previously (Salehi et al., 1999). The surgical procedures used in the in vitro
and in vivo studies were approved by the ethical committee at Lund University.
Isolation of Islets and Hormone Release Assays
For the static hormone release measurements, adult mice were killed by
cervical dislocation, the pancreas quickly excised, and pancreatic islets iso-
lated by standard collagenase digestion. Insulin and glucagon secretion
were measured in a KRB buffer as described previously (Salehi et al., 1999).
Total insulin islet content was determined after extraction with acidic ethanol.
Comparison of insulin/proinsulin release was made using rat/mouse proinsulin
and mouse insulin ELISAs (Mercodia; Uppsala).
Imaging and Electrophysiology
Electron microscopy and fura-2 measurements of [Ca2+]i in intact islets were
performed as described previously (Olofsson et al., 2002).
Capacitance recordings of single b cell exocytosis were performed using the
standard whole-cell technique and procedures described previously (Barg
et al., 2001). The extracellular medium consisted of 118 mM NaCl, 20 mM
TEA-Cl, 5.6 mM KCl, 1.2 mM MgCl2, 2.6 mM CaCl2, 5 mM D-glucose, and
5 mM HEPES (pH 7.4 with NaOH). The standard electrode (intracellular) solu-
tion contained 125 mM Cs-glutamate, 10 mM KCl, 10 mM NaCl, 1 mM MgCl2,
5 mM HEPES, 0.05 mM EGTA, 3 mM Mg-ATP, and 0.1 mM cAMP (pH 7.15 with
KOH). In the experiments in Figure 3A, glutamate was added as monopotas-
sium salt, and [Ca2+]i was buffered to 1.5 mM (Ivarsson et al., 2005) by inclu-
sion of 10 mM EGTA and 9 mM CaCl2. For rescue experiments (Figures 2E and
2F), ClC-3/ islets were infected with a ClC-3-encoding recombinant SFV
prior to dispersion into single cells and then cultured overnight.
Insulin Granule Fractionation and pH Measurements
Granular pH was monitored semiquantitatively as outlined elsewhere (Barg
et al., 2001) using LSG (5 mM) (Invitrogen AB, Stockholm). Insulin granule spec-
ificity of LSG fluorescence was evaluated using cells infected with an in-house
IAPP-Cherry adenoviral construct. Granule fluorescence was visualized by
total internal reflection fluorescence microscopy (Hoppa et al., 2009).
A highly enriched LDCV fraction was obtained by using a recombinant phog-
rin-EGFP adenovirus made using the BD Adeno-X expression system 1 (Clon-
tech; Mountain View, CA). INS-1 cells were infected for 1 hr and homogenized
after 36 hr culture. The postnuclear supernatant was pelleted (50003 g for 15
min, 4C) and resuspended in a sorting buffer containing 135 mM KCl, 10 mMnc.
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Ablation of ClC-3 Suppresses Insulin SecretionNaCl, 1 mM MgCl2, 5 mM HEPES, 2 mM EGTA (pH 7.15 with KOH), and 0.1%
BSA in the immunostaining and electron microscopy experiments, but not for
immunoblotting or when insulin content was determined. EGFP-positive parti-
cles were collected using a Becton Dickinson cell sorter (San Jose, CA) and
tested for insulin and protein content (Figure 3D). For immunostaining
(Figure 3E), the sorted granules were attached on polylysin-coated coverslips,
followed by fixation, permeabilization, and overnight incubation at 4C with
guinea pig anti-insulin (1:100) and rabbit anti-ClC-3 (1:100) primary antibodies.
After washing, the granules were incubated at 22C with donkey-raised
secondary antibodies (Cy3-anti-guinea pig [1:400] and Cy5-anti-rabbit
[1:400]) and analyzed using a Zeiss LSM 510 confocal microscope. Negative
immuno-EM was performed as previously outlined (Wiberg et al., 2001) using
the same primary antibodies, coupled to 5 nm (insulin) or 25 nm (ClC-3) gold
particles.
RNA Interference and GH Release in INS-1 Cells
ClC-3 silencing was accomplished using the EGFP-containing PRNA-H1.1
vector (GenScript Corp.; Piscataway, NJ) with 76 bp shRNA inserts. EGFP-ex-
pressing cells were collected 72 hr postinfection using a Becton Dickinson cell
sorter. Efficiency of silencing was estimated by immunoblotting for ClC-3. The
most efficient silencer construct (S3) contained the CTCCGGAATTCCAGA
GATTAA target sequence in rat ClC-3 and was used for all functional assays.
Human growth hormone (hGH) secretion was measured in INS-1 cells using
0.2 mg of the S3 silencer or scrambled control oligo inserted into the PRNA-H1.1
vector and 0.2 mg of the hGH-expressing vector, as previously detailed (Ivars-
son et al., 2005).
Data are quoted as mean values ± SEM of indicated number of experiments.
Statistical significance was evaluated using Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include three figures and can be found online at http://
www.cell.com/cell-metabolism/supplemental/S1550-4131(09)00261-7.
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